drugset
drugset / Trial / NCT00004096

Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00004096 ↗

Phase 1/2 Completed Northwestern University National Cancer Institute (NCI) · collab
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combining carboplatin and vinorelbine in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Timeline

Start
1999-08
Primary completion
2002-03
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Vinorelbine Small molecule — Intravenous
Background Carboplatin Small molecule — Intravenous

Indications

lung cancer